134 studies found for:    Open Studies | "Thyroid Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia
Conditions: Thyroid Neoplasms;   Thyroid Cancer
Intervention: Procedure: Histological investigation of the SN
2 Not yet recruiting PET Evaluation of Recurrent Differentiated Thyroid Cancer
Conditions: Thyroid Neoplasms;   Differentiated Thyroid Cancer
Intervention:
3 Recruiting Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Conditions: Follicular Thyroid Cancer;   Insular Thyroid Cancer;   Papillary Thyroid Cancer;   Recurrent Thyroid Cancer
Interventions: Drug: dabrafenib;   Drug: trametinib;   Other: Correlative Studies
4 Recruiting Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
Conditions: Papillary Thyroid Cancer;   Follicular Thyroid Cancer;   Differentiated Thyroid Cancer
Intervention: Drug: SU011248, Sutent
5 Recruiting Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study
Conditions: Papillary Carcinoma of Thyroid Metastatic to Regional Lymph Node;   Metastatic Medullary Thyroid Cancer;   Follicular Thyroid Cancer Lymph Node Metastasis
Interventions: Drug: Ferumoxytol;   Device: lymphotrophic superparamagnetic nanoparticles (LSN MRI).
6 Not yet recruiting A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Thyroid Cancer
Intervention: Drug: MLN0128
7 Unknown  An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
Conditions: Thyroid Neoplasms;   Head and Neck Neoplasms
Interventions: Drug: C-PERT;   Drug: G-PERT
8 Recruiting Nintedanib(BIBF1120) in Thyroid Cancer
Conditions: Medullary Thyroid Cancer (MTC);   Differentiated Thyroid Cancer (DTC)
Interventions: Drug: Nintedanib;   Drug: Placebo
9 Recruiting A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Conditions: Differentiated Thyroid Cancer (DTC);   Poorly Differentiated Thyroid Cancer
Intervention: Drug: Cabozantinib
10 Recruiting Dabrafenib and Lapatinib Ditosylate in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
Conditions: Anaplastic Thyroid Cancer;   Insular Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer;   Thyroid Gland Medullary Carcinoma;   Thyroid Gland Nonmedullary Carcinoma
Interventions: Drug: lapatinib ditosylate;   Drug: dabrafenib;   Other: pharmacological study;   Other: laboratory biomarker analysis
11 Recruiting Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Conditions: Insular Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage I Follicular Thyroid Cancer;   Stage I Papillary Thyroid Cancer;   Stage II Follicular Thyroid Cancer;   Stage II Papillary Thyroid Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Papillary Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis
12 Recruiting Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
Conditions: Recurrent Thyroid Cancer;   Stage I Follicular Thyroid Cancer;   Stage I Papillary Thyroid Cancer;   Stage II Follicular Thyroid Cancer;   Stage II Papillary Thyroid Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Papillary Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer
Interventions: Drug: cediranib maleate;   Drug: lenalidomide;   Other: laboratory biomarker analysis
13 Recruiting A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Condition: Thyroid Neoplasm
Interventions: Drug: Valproic Acid;   Drug: Liothyronine Sodium
14 Recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Recurrent Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer
Interventions: Radiation: iodine I 124;   Procedure: positron emission tomography;   Procedure: computed tomography;   Drug: trametinib;   Radiation: iodine I 131;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Not yet recruiting Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Thyroid Cancer
Conditions: Recurrent Thyroid Cancer;   Stage III Follicular Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer
Interventions: Drug: sorafenib;   Drug: everolimus
16 Recruiting Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients
Condition: Thyroid Carcinoma
Intervention: Drug: Sorafenib (Nexavar,BAY43-9006)
17 Recruiting Pioglitazone in Follicular or Follicular Variant of Papillary Thyroid Cancers
Conditions: Follicular Thyroid Carcinoma;   Follicular Variant of Papillary Thyroid Carcinoma
Intervention: Drug: Pioglitazone
18 Unknown  Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma
Condition: Thyroid Carcinoma
Intervention: Procedure: thyroidectomy
19 Unknown  Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
Condition: Papillary Thyroid Carcinoma
Intervention: Drug: GSK2118436
20 Recruiting The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
Conditions: Thyroid Carcinoma;   Hypothyroidism
Interventions: Other: Black Coffee;   Other: Coffee with Milk;   Other: Black Tea;   Other: Water

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years